| Year |
Citation |
Score |
| 2019 |
Lin L, Rybak AP, Rinaldi C, Yen J, Fu Y, Akrawi E, Smith S, Haskett SJ, Sanchez ME, Poh Y, Packer MS, Gaudelli NM, Singh M, Ciaramella G, Levasseur DN. Complementary Base Editing Approaches for the Treatment of Sickle Cell Disease and Beta Thalassemia Blood. 134: 3352-3352. DOI: 10.1182/Blood-2019-126710 |
0.436 |
|
| 2018 |
Psatha N, Reik A, Phelps S, Zhou Y, Dalas D, Yannaki E, Levasseur DN, Urnov FD, Holmes MC, Papayannopoulou T. Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major. Molecular Therapy. Methods & Clinical Development. 10: 313-326. PMID 30182035 DOI: 10.1016/J.Omtm.2018.08.003 |
0.507 |
|
| 2018 |
Moran K, Ling H, Lessard S, Vieira B, Hong V, Holmes MC, Reik A, Dang D, Gray D, Levasseur D, Rimmele P. Ex Vivo Gene-Edited Cell Therapy for Sickle Cell Disease: Disruption of the BCL11A Erythroid Enhancer with Zinc Finger Nucleases Increases Fetal Hemoglobin in Plerixafor Mobilized Human CD34+ Cells Blood. 132: 2190-2190. DOI: 10.1182/Blood-2018-99-116998 |
0.541 |
|
| 2017 |
Xiao S, Lu J, Sridhar B, Cao X, Yu P, Zhao T, Chen CC, McDee D, Sloofman L, Wang Y, Rivas-Astroza M, Telugu BP, Levasseur D, Zhang K, Liang H, et al. SMARCAD1 Contributes to the Regulation of Naive Pluripotency by Interacting with Histone Citrullination. Cell Reports. 18: 3117-3128. PMID 28355564 DOI: 10.1016/J.Celrep.2017.02.070 |
0.407 |
|
| 2015 |
Songstad AE, Wiley LA, Duong K, Kaalberg E, Flamme-Wiese MJ, Cranston CM, Riker MJ, Levasseur D, Stone EM, Mullins RF, Tucker BA. Generating iPSC-Derived Choroidal Endothelial Cells to Study Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 56: 8258-67. PMID 26720480 DOI: 10.1167/Iovs.15-17073 |
0.614 |
|
| 2015 |
Yang Y, Shi J, Gu Z, Salama ME, Das S, Wendlandt E, Xu H, Huang J, Tao Y, Hao M, Franqui R, Levasseur D, Janz S, Tricot G, Zhan F. Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma. Cancer Research. 75: 594-604. PMID 25589346 DOI: 10.1158/0008-5472.Can-14-2362 |
0.552 |
|
| 2014 |
Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T, Sandstrom R, Ma Z, Davis C, Pope BD, Shen Y, Pervouchine DD, Djebali S, Thurman RE, Kaul R, ... ... Levasseur D, et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature. 515: 355-64. PMID 25409824 DOI: 10.1038/Nature13992 |
0.351 |
|
| 2014 |
Duong KL, Das S, Yu S, Barr JY, Jena S, Kim E, Zavazava N, Colgan JD, Xue HH, Levasseur DN. Identification of hematopoietic-specific regulatory elements from the CD45 gene and use for lentiviral tracking of transplanted cells. Experimental Hematology. 42: 761-72.e1-10. PMID 24852660 DOI: 10.1016/J.Exphem.2014.05.005 |
0.625 |
|
| 2013 |
Zhou W, Yang Y, Gu Z, Wang H, Xia J, Wu X, Zhan X, Levasseur D, Zhou Y, Janz S, Tricot G, Shi J, Zhan F. ALDH1 activity identifies tumor-initiating cells and links to chromosomal instability signatures in multiple myeloma. Leukemia. 28: 1155-8. PMID 24365790 DOI: 10.1038/Leu.2013.383 |
0.327 |
|
| 2013 |
Li X, Rossen N, Sinn PL, Hornick AL, Steines BR, Karp PH, Ernst SE, Adam RJ, Moninger TO, Levasseur DN, Zabner J. Integrin α6β4 identifies human distal lung epithelial progenitor cells with potential as a cell-based therapy for cystic fibrosis lung disease. Plos One. 8: e83624. PMID 24349537 DOI: 10.1371/Journal.Pone.0083624 |
0.559 |
|
| 2013 |
Yang Y, Shi J, Tolomelli G, Xu H, Xia J, Wang H, Zhou W, Zhou Y, Das S, Gu Z, Levasseur D, Zhan F, Tricot G. RARα2 expression confers myeloma stem cell features. Blood. 122: 1437-47. PMID 23847194 DOI: 10.1182/Blood-2013-02-482919 |
0.514 |
|
| 2013 |
Das S, Levasseur D. Transcriptional regulatory mechanisms that govern embryonic stem cell fate. Methods in Molecular Biology (Clifton, N.J.). 1029: 191-203. PMID 23756950 DOI: 10.1007/978-1-62703-478-4_13 |
0.531 |
|
| 2013 |
Costa Y, Ding J, Theunissen TW, Faiola F, Hore TA, Shliaha PV, Fidalgo M, Saunders A, Lawrence M, Dietmann S, Das S, Levasseur DN, Li Z, Xu M, Reik W, et al. NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature. 495: 370-4. PMID 23395962 DOI: 10.1038/Nature11925 |
0.532 |
|
| 2012 |
Das S, Jena S, Kim EM, Zavazava N, Levasseur DN. Transcriptional Regulation of Human NANOG by Alternate Promoters in Embryonic Stem Cells. Journal of Stem Cell Research & Therapy. 009. PMID 25077040 DOI: 10.4172/2157-7633.S10-009 |
0.5 |
|
| 2011 |
Das S, Jena S, Levasseur DN. Alternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells. The Journal of Biological Chemistry. 286: 42690-703. PMID 21969378 DOI: 10.1074/Jbc.M111.290189 |
0.503 |
|
| 2008 |
Orkin SH, Wang J, Kim J, Chu J, Rao S, Theunissen TW, Shen X, Levasseur DN. The transcriptional network controlling pluripotency in ES cells Cold Spring Harbor Symposia On Quantitative Biology. 73: 195-202. PMID 19478325 DOI: 10.1101/Sqb.2008.72.001 |
0.553 |
|
| 2008 |
Wang J, Levasseur DN, Orkin SH. Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. Proceedings of the National Academy of Sciences of the United States of America. 105: 6326-31. PMID 18436640 DOI: 10.1073/Pnas.0802288105 |
0.583 |
|
| 2008 |
Levasseur DN, Wang J, Dorschner MO, Stamatoyannopoulos JA, Orkin SH. Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells. Genes & Development. 22: 575-80. PMID 18283123 DOI: 10.1101/Gad.1606308 |
0.569 |
|
| 2008 |
Wang J, Levasseur DN, Orkin SH. Requirement of Nanog dimerization for stem cell self-renewal and pluripotency (Proceedings of the National Academy of Sciences of the United States of America (2008) 105:17 (6326-6331) DOI: 10.1073/pnas.0802288105) Proceedings of the National Academy of Sciences of the United States of America. 105: 8801-8802. DOI: 10.1073/pnas.0804442105 |
0.371 |
|
| 2007 |
Wang J, Rao S, Chu J, Shen X, Levasseur D, Theunissen T, Orkin S. Protein interaction network for pluripotency of ES cells: Possible clues to organization of self-renewal machinery in other stem cells Blood Cells, Molecules, and Diseases. 38: 164. DOI: 10.1016/J.Bcmd.2006.10.103 |
0.438 |
|
| 2006 |
Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, Orkin SH. A protein interaction network for pluripotency of embryonic stem cells. Nature. 444: 364-8. PMID 17093407 DOI: 10.1038/Nature05284 |
0.541 |
|
| 2006 |
Hill AE, Hong JS, Wen H, Teng L, McPherson DT, McPherson SA, Levasseur DN, Sorscher EJ. Micro-RNA-like effects of complete intronic sequences. Frontiers in Bioscience : a Journal and Virtual Library. 11: 1998-2006. PMID 16368574 DOI: 10.2741/1941 |
0.365 |
|
| 2004 |
Hong JS, Waud WR, Levasseur DN, Townes TM, Wen H, McPherson SA, Moore BA, Bebok Z, Allan PW, Secrist JA, Parker WB, Sorscher EJ. Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene. Cancer Research. 64: 6610-5. PMID 15374975 DOI: 10.1158/0008-5472.Can-04-0012 |
0.307 |
|
| 2003 |
Bennett EM, Anand R, Allan PW, Hassan AE, Hong JS, Levasseur DN, McPherson DT, Parker WB, Secrist JA, Sorscher EJ, Townes TM, Waud WR, Ealick SE. Designer gene therapy using an Escherichia coli purine nucleoside phosphorylase/prodrug system. Chemistry & Biology. 10: 1173-81. PMID 14700625 DOI: 10.1016/J.Chembiol.2003.11.008 |
0.345 |
|
| 2003 |
Levasseur DN, Ryan TM, Pawlik KM, Townes TM. Correction of a mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells. Blood. 102: 4312-9. PMID 12933581 DOI: 10.1182/Blood-2003-04-1251 |
0.499 |
|
| 2000 |
Chen W, Wu X, Levasseur DN, Liu H, Lai L, Kappes JC, Townes TM. Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice Stem Cells. 18: 352-359. PMID 11007919 DOI: 10.1634/Stemcells.18-5-352 |
0.597 |
|
| Show low-probability matches. |